PlainRecalls
FDA Drug Critical Class I Ongoing

HYDROCODONE BITARTRATE and ACETAMINOPHEN TABLETS, USP, 10 mg/500 mg, 100-count bottle, Rx only, Mfg. for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-3888-21

Reported: November 28, 2012 Initiated: September 10, 2012 #D-057-2013

Product Description

HYDROCODONE BITARTRATE and ACETAMINOPHEN TABLETS, USP, 10 mg/500 mg, 100-count bottle, Rx only, Mfg. for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-3888-21

Reason for Recall

Superpotent (Multiple Ingredient) Drug: Confirmed customer complaints of oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.

Details

Units Affected
14,445 bottles
Distribution
Nationwide.
Location
Huntsville, AL

Frequently Asked Questions

What product was recalled?
HYDROCODONE BITARTRATE and ACETAMINOPHEN TABLETS, USP, 10 mg/500 mg, 100-count bottle, Rx only, Mfg. for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-3888-21. Recalled by Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals. Units affected: 14,445 bottles.
Why was this product recalled?
Superpotent (Multiple Ingredient) Drug: Confirmed customer complaints of oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 28, 2012. Severity: Critical. Recall number: D-057-2013.